Udg Healthcare (LON:UDG) cover image
284 Reads (1 min read)

Upbeat broker recommendations for Udg Healthcare

27th Jan '21 by Michael Green

The Udg Healthcare (LON:UDG) share price has risen by 3.33% over the past month and it’s currently trading at 832.5. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Udg Healthcare currently has:

  • 3 Buy recommendations
  • 2 Hold recommendations
  • 1 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO LON:UDG »

Looking behind the broker forecasts

At its current price of 832.5, shares in Udg Healthcare are trading at a discount of -0.90% to its 52 week high price. The 1-year performance of the shares has been 3.59%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Udg Healthcare it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Udg Healthcare that you can find out about here.

Share this article
As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.
Share Price
1079p
Change Today
1%
Udg Healthcare ( )

Stockopedia is here to help individual investors beat the markets by being the very best in stock analysis, research & community. Take a 30 day free trial of our extensive multi-award winning service and find out why more than ten thousand global investors can't live without it.

© Stockopedia 2024, Refinitiv, Share Data Services.

*Past performance is no indicator of future performance. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of Use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.

{"statusCode":500,"message":"Internal server error"}